SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-15-072773
Filing Date
2015-12-24
Accepted
2015-12-24 12:49:20
Documents
2
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13D v427761_sc13d.htm SC 13D 123082
2 EXHIBIT 99.1 v427761_ex99-1.htm EX-99.1 6272
  Complete submission text file 0001144204-15-072773.txt   131166
Mailing Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Subject) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88493 | Film No.: 151307645
SIC: 2834 Pharmaceutical Preparations